Webinar | January 6, 2021

Benefits Of 5KL Bioreactor When Outsourcing Late-Phase Biologics Drug Substance Manufacturing

When you look at the current challenges in upstream bioprocessing, two come to the forefront as critical. The first is intensified cell culture processes which present a challenge for the bioreactor space—specifically for improving the mixing and mass transfer of performance. The second is a demand for flexible and efficient manufacturing which is driven by a shift in volumetric demand profiles.

Watch this webinar today and discover how Thermo Fisher Scientific is addressing and overcoming these two challenges of bioprocessing.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: